Evaluation of the Safety and Efficacy of EXPAREL (Bupivacaine Liposome Injectable Suspension) When Administered Via Infiltration Versus Instillation in Subjects Undergoing Bilateral Augmentation Mammoplasty
Phase of Trial: Phase IV
Latest Information Update: 03 Sep 2014
At a glance
- Drugs Bupivacaine (Primary) ; Bupivacaine (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- Sponsors Pacira Pharmaceuticals
- 01 Dec 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 09 Jul 2012 Official Title amended as reported by ClinicalTrials.gov.
- 28 Apr 2012 New trial record